BOLD · Boundless Bio Inc
United States · RS rating 69 · As of 2026-11-03
| Price | 2.38 USD |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 69 / 38 / 37 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 36 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +6.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +20.7% |
| Market cap (USD) | $34.1M |